The failure of Russia’s recent RS-28 Sarmat intercontinental ballistic missile test points to potential propulsion issues, complicating Moscow’s strategic deterrent and future nuclear balance ...

The world's nuclear giants are flexing their muscles in new long-range missile tests as the high-stakes game of deterrence ...

A frequently used thesis in such materials with a claim to analyticity is an indication that President Vladimir Putin has ...

In September, Moscow attempted to test its latest intercontinental ballistic missile, the RS-28 Sarmat, also known as Satan II, and proclaimed the "world's deadliest" nuclear weapon by Russian ...

The RS-28 Sarmat is the Russian promising silo-based missile complex with the heavy liquid-propellant ICBM capable of carrying nuclear charges. Russia has been developing the Sarmat since the ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

New Delhi: Sagility India Ltd, a technology-enabled services provider in the healthcare space, on Wednesday said it has fixed a price band of Rs 28-30 per share for its Rs 2,107 crore initial ...

EQT Private Capital-backed Sagility India, the healthcare focussed services provider, will launch its Rs 2,107-crore initial share sale on November 5, with a price band at Rs 28-30 per share.

Apart from joining NATO, Ukraine’s only option would be nuclear weapons, Volodymyr Zelenskyy told the European Council earlier this week while discussing what needs to be done to protect the ...